Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
AssigneeAbbott Diabetes Care Inc.
InventorsMarc B. Taub, Jai Karan, Annie C. Tan, Timothy C. Dunn, Joel M. Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
Life of this patent
Estimating the term…
Abstract
Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.
Claims20
A method of operating an electronic device in an analyte monitoring system, comprising:
- displaying an insulin dose calculation screen;
- exiting the insulin dose calculation screen before logging a calculated dose that is based on a result of a first analyte measurement;
- permitting logging of the calculated dose for a predetermined period of time after the first analyte measurement;
- and
- preventing logging of the calculated dose after the predetermined period of time after the first analyte measurement.
An electronic device, comprising:
- a display;
- and
- processor circuitry operably coupled with the display and configured to:
- cause display of an insulin dose calculation screen on the display;
- permit, after the insulin dose calculation screen is exited and before a calculated dose is logged, a logging of the calculated dose if a predetermined period of time after a first analyte measurement has not lapsed, wherein the calculated dose is based on a result of the first analyte measurement;
- and
- prevent the logging of the calculated dose after the predetermined period of time after the first analyte measurement has lapsed.
Dependencies are inferred from the claim text.